{"name":"BioArctic AB","slug":"bioarctic-ab","ticker":"","exchange":"","domain":"bioarcticab.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"exidavnemab","genericName":"exidavnemab","slug":"exidavnemab","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"exidavnemab","genericName":"exidavnemab","slug":"exidavnemab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-16","type":"earnings","source":"simplywall.st","summary":"BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - simplywall.st","headline":"BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNNTkteHJNWGpKN2dwTkluWWpNUE12d1FHVElva19LVGFZRWM4cmdkdWJ0bm5iVkV3SDVqQ0JsbXdoaWg4NHZINm9rWTN3NHpRcU5aMXlpbVN5REpZSHN0dl9uTmlCUl93ZklTLTZGbjVOM3F0eDh2RC1WY2xHTEx6TC1lTVpodUlHUE9lUXZaUXhSa1NzY3VHcXZfQjA3YV9CWVNWZEcybExUQmJjYnc?oc=5","date":"2025-10-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"From Nobel to next-gen: Sweden’s quiet life sciences ascent - Pharmaceutical Technology","headline":"From Nobel to next-gen: Sweden’s quiet life sciences ascent","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-07","type":"pipeline","source":"simplywall.st","summary":"Is BioArctic AB (publ)'s (STO:BIOA B) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st","headline":"Is BioArctic AB (publ)'s (STO:BIOA B) Latest Stock Performance A Reflection Of Its Financial Health?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQekVrRkw3QUVZcnNhRWtIY1hGUk9ra3k1NUJwLUZ5dEZuNXgxUm1rcTB4dm5jcS01S0gwZ0ZJQ0xfWldxdHJsWk5sbGhrUTd4bnBKTklHMmlueF9UWEVmWUNlTWF6SXFYQnpaZnNwRDlvdDlvTWlqcGwwUWFGRGRHZ2UyV0hfalV3VmE1cl80cWw5ekdGY3R0Wl93?oc=5","date":"2025-09-09","type":"pipeline","source":"Uppsala universitet","summary":"BioArctic CEO Gunilla Osswald is Alumnus of the Year - Uppsala universitet","headline":"BioArctic CEO Gunilla Osswald is Alumnus of the Year","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-31","type":"pipeline","source":"medicaldialogues.in","summary":"BioArctic inks pact with Novartis regarding treatment combining BrainTransporter technology with... - medicaldialogues.in","headline":"BioArctic inks pact with Novartis regarding treatment combining BrainTransporter technology with...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMWoxWnNjU3JVN2FKWWpSeGQyMzU5YzJ2RU9ISlVPQ181RVV3TEtkTWRFbnVUY1o5eWU4NjJQdk9CUDFrVjk3Zmc4TGljXy1oOURDMGdtUnRPaGx4ZUl6SlNGN3BZZlI2dGQ1eXBJRUdWanBLWkFPbnhERUdRQmQzUEM2Tmh2NFBFZzV4UTJoOVlQNWJ3SUNBSW5ZOElORzVVeTZCRg?oc=5","date":"2025-08-27","type":"deal","source":"Contract Pharma","summary":"Novartis Licenses BioArctic’s BrainTransporter Technology - Contract Pharma","headline":"Novartis Licenses BioArctic’s BrainTransporter Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNNkhXby1LZjI5Q2ZGa0NEdWxHbnJkTDhaLWdnNzFzWjFSNUo3bmg0bGJ2MlJEeHlOTy1xd1dfQTF4SXVqRlBiUlVVSkMtOHhJaDI2VUt5NUF3N3Bobl9MUzVMaThiQmRTNTRndjRyenFkdktSY2FEeElPYk5qOExSaUxGdlNMUDJqQldFSTBTOXJ0d1M1V3BYUHJCMXd1MHN2SzNuVVhhWXRheGpMTjBGZWM5U0F1dw?oc=5","date":"2025-08-26","type":"pipeline","source":"Fierce Biotech","summary":"Novartis pens BioArctic pact worth $30M upfront to find new drug in neurodegeneration field - Fierce Biotech","headline":"Novartis pens BioArctic pact worth $30M upfront to find new drug in neurodegeneration field","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQYmhGNVBrSktPV0NMZ3FfRTgxQlhMc2FPYTF1SlljZUY2bDJWU09KOHdGakJLYVFIYVZrV2Nfa2dnRFhHd2N0aXJUM0JhT1RuSm5GUXN6bm9Wa3F1bG9haURQUUhwZEFYRk9CWjdLRzFNSDZjSThFc3BFdjFUcllTYzVfdzNwSWxSdm5oR1k0OVB6T3YybWU3SmxyNm56ekw3bElsYV9KT3hKT1pJTnJFbw?oc=5","date":"2025-08-26","type":"deal","source":"Pharmaceutical Executive","summary":"Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration - Pharmaceutical Executive","headline":"Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxONGRxMGwyTEp4VXpzVXJCbGV6MGVMb3JtVVFER2hKb1kyd21aZnRna1NkNXFZRXJQT3pTb0lzNTdhRlRHTUcyNkt0aDlIRGU1UGZfT2loQVQ5ODgwRk9aaXhtT2VweVNId2lkUER6NWdkNU52LUYxSkZPV25YR0xIRmJ1Z2t5WVNZTG1mb1NIVEVyWTYwdktCb3ZPMGc?oc=5","date":"2025-08-25","type":"regulatory","source":"European Biotechnology Magazine","summary":"Alzheimer’s antibody Lecanemab launched in the EU - European Biotechnology Magazine","headline":"Alzheimer’s antibody Lecanemab launched in the EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNUzVob0J3WVAtSU1xVjBLTHh0TkJOMnk0THZSbUlKMWVVcTBxX0RHZnVjdVBhZ1FhR2FOM1l5Y0dnd04wYmtMQTRiTE51Y1BtNG9aR2RpMVVUbkpPTU1LdDlKUlVTcXhGUEhlWG1NNVN0Yk0tNXhnbUFrWWE0SGNubDIzZWc2UU1zZnM3MnNBSXdtRndtSlo5MjB1bS02TmlLMUZLODVIWQ?oc=5","date":"2025-03-11","type":"deal","source":"European Pharmaceutical Review","summary":"Bristol Myers Squibb to acquire 2seventy bio - European Pharmaceutical Review","headline":"Bristol Myers Squibb to acquire 2seventy bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQam50THRpS3hXYjJESmdQUV9WWTBSWUE0QWJNb2VsS296RTkwRG1LREFLSk1GRVpLZ2N3RHB4dWVVQy1rb2hrMG5FQjF6dGdCM2JXcWRKMHlPYXc5ZjB5blV3TTZvMl9sYTZRT09rNzIwSjc0cExaTlBWZm1adWhPdjBXN29tcS1mNUxyNmFrNU5QWHcxNkw3WE5IMUpVUVBPcE9pWi10VlJNaVV2dHNoQm82WTRYaEVLX2RNbmJkZ0hCY05jZUtqU2pSZHc5WkJwcDdwSkgtVlNjMExSam9vUA?oc=5","date":"2024-03-22","type":"pipeline","source":"reuters.com","summary":"EU regulator delays decision on Eisai-Biogen Alzheimer's drug - reuters.com","headline":"EU regulator delays decision on Eisai-Biogen Alzheimer's drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}